XFOR

Conviction 70HealthcareScan · Fri, Aug 7, 2026

XFOR$4.63+10.91%

ResistanceSupportVol 14Insider sell

Vol MA14 1.74M

May 8May 27Jun 15Jul 2Jul 22Aug 7

X4 Pharmaceuticals, IncBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.x4pharma.com ↗

Price4.63

Change+10.91%

Gap+3.36%

Rel volume28.75×

Avg volume1.42M

Avg $ vol6.18M

SMA 203.99

SMA 504.03

SMA 2003.89

Price vs 50+14.88%

Price vs 200+18.83%

MA stackbullish

50/200 cross—

Supertrendup · 3.76

RSI (14)67

MACD hist0.07

MACD crossbull · 7d

Stoch %K / %D85 / 80

ADX (14)20

+DI / −DI36 / 12

RSI divergence—

MACD divergence—

ATR %+5.67%

ADR %6.03%

52w high4.67

52w low1.42

From 52w high-0.96%

Above 52w low+225.70%

New 52w highNo

SqueezeOff

Bollinger width21.61%

%B1.24

Donchian pos84.52%

Donchian high4.82

Donchian low3.56

AVWAP (52w high)3.91

vs AVWAP high+18.15%

AVWAP (52w low)3.25

vs AVWAP low+42.11%

OBV trendUp

Chaikin MF (20)0.18

Today vs 20d28.75×

Avg vol (14d)1.74M

Avg vol (20d)1.42M

Avg $ vol (20d)6.18M

Market cap458.55M

RS 3m (vs SPY)-9.53%

RS 6m (vs SPY)-3.69%

RS line new highNo

Trend template7/8

Technical rank80.1

1 week+16.21%

1 month+16.79%

3 months+7.81%

6 months+26.37%

1 year+192.72%

YTD+18.89%

P/E-5.79

P/B2.95

P/S13.06

P/FCF-5.34

EPS-1.87

Div yield—

ROE-50.95%

ROA-31.30%

Debt/Eq0.35

Current11.30

EV/EBITDA-3.71

Gross margin—

Net margin-225.55%

Rev growth1273.21%

EPS growth-111.48%

Price target11.25

Target upside143.24%

Analyst ratingBuy

Institutional114.19%

Ent. value318.03M

Revenue8.81M

Net income-16.16M

Gross profit—

Free cash flow-85.94M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out94.32M

Employees45

ListedThu, Nov 16, 2017

Free float88.8M

Float %94.2%

Short interest6.5M

Days to cover9.8d

Short volume22.8%

Squeeze score55 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.13 vs −$0.19

Last surprise+31.6% beat

Setup gradeB

Conviction70 / 100

Pattern quality—

Tech rank80.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.70

Support3.64

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XFOR

All disclosures →

No recent disclosed trades by Congress in XFOR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XFOR · 1 sell

Insider	Side	Shares	Value	Traded	Filed
KIRSKE DAVID Chief Financial Officer · Common Stock · 2026-05-12	Sell	16.96K	$73K	2026-05-12	2026-05-13

SEC filings

EDGAR filings in XFOR · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.